A cross‐sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update

PURPOSE: We evaluated the effectiveness of additional risk minimisation measures (aRMMs; i.e., educational materials) distributed to prescribers to ensure that only individuals with evidence of prior dengue infection (PDI, i.e., dengue seropositive) would be vaccinated with the tetravalent dengue va...

Descripción completa

Detalles Bibliográficos
Autores principales: Almas, Mariana F., Toussi, Massoud, Valero, Elisa, Moureau, Annick, Marcelon, Lydie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325459/
https://www.ncbi.nlm.nih.gov/pubmed/35505623
http://dx.doi.org/10.1002/pds.5447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325459/
https://www.ncbi.nlm.nih.gov/pubmed/35505623
http://dx.doi.org/10.1002/pds.5447

Ejemplares similares